Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.49
-0.06-0.63%
At close: -
$9.49
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Bicycle Therapeutics Analyst Ratings and Price Targets | NASDAQ:BCYC | Benzinga
Bicycle Therapeutics PLC has a consensus price target of $37.13 based on the ratings of 17 analysts. The high is $60 issued by Canaccord Genuity on February 21, 2024. The low is $15 issued by Stephens & Co. on January 22, 2025. The 3 most-recent analyst ratings were released by Needham, Citizens Capital Markets, and HC Wainwright & Co. on March 11, 2025, February 26, 2025, and February 26, 2025, respectively. With an average price target of $29.67 between Needham, Citizens Capital Markets, and HC Wainwright & Co., there's an implied 212.61% upside for Bicycle Therapeutics PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Citizens Capital Markets
HC Wainwright & Co.
Stephens & Co.
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Bicycle Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | Buy Now | 216.12% | Needham | Ami Fadia62% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2025 | Buy Now | 173.97% | Citizens Capital Markets | Reni Benjamin46% | $26 → $26 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/26/2025 | Buy Now | 247.73% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2025 | Buy Now | 216.12% | Needham | Ami Fadia62% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | Buy Now | 58.06% | Stephens & Co. | Sudan Loganathan31% | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 01/13/2025 | Buy Now | 247.73% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 237.2% | Needham | Ami Fadia62% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2024 | Buy Now | 173.97% | JMP Securities | Reni Benjamin46% | $32 → $26 | Maintains | Market Outperform | Get Alert |
| 12/16/2024 | Buy Now | 247.73% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $33 | Maintains | Buy | Get Alert |
| 12/13/2024 | Buy Now | 79.14% | B. Riley Securities | Kalpit Patel40% | $28 → $17 | Maintains | Neutral | Get Alert |
| 11/08/2024 | Buy Now | 163.44% | Stephens & Co. | Sudan Loganathan31% | → $25 | Initiates | → Equal-Weight | Get Alert |
| 11/01/2024 | Buy Now | 268.81% | RBC Capital | Gregory Renza49% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 11/01/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | 300.42% | Needham | Ami Fadia62% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2024 | Buy Now | 300.42% | Needham | Ami Fadia62% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 09/16/2024 | Buy Now | 237.2% | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/16/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 09/16/2024 | Buy Now | 300.42% | Needham | Ami Fadia62% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 09/09/2024 | Buy Now | 300.42% | Needham | Ami Fadia62% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek41% | — | Reiterates | → Overweight | Get Alert |
| 09/06/2024 | Buy Now | 268.81% | RBC Capital | Gregory Renza49% | → $35 | Initiates | → Outperform | Get Alert |
| 08/07/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 405.8% | Oppenheimer | Jay Olson62% | $48 → $48 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 300.42% | Needham | Ami Fadia62% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 195.05% | B. Riley Securities | Kalpit Patel40% | $33 → $28 | Downgrade | Buy → Neutral | Get Alert |
| 05/03/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $55 → $55 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2024 | Buy Now | 353.11% | Needham | Ami Fadia62% | $43 → $43 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | 353.11% | Needham | Ami Fadia62% | $43 → $43 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | 532.24% | Canaccord Genuity | Bill Maughan19% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | 479.56% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $57 → $55 | Maintains | Buy | Get Alert |
| 12/20/2023 | Buy Now | 237.2% | JMP Securities | Reni Benjamin46% | $44 → $32 | Maintains | Market Outperform | Get Alert |
| 12/15/2023 | Buy Now | 353.11% | Needham | Ami Fadia62% | $46 → $43 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 584.93% | Cantor Fitzgerald | Li Watsek41% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | 321.5% | Morgan Stanley | Jeffrey Hung56% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 09/12/2023 | Buy Now | 247.73% | B. Riley Securities | Kalpit Patel40% | → $33 | Upgrade | Neutral → Buy | Get Alert |
| 09/12/2023 | Buy Now | 584.93% | Cantor Fitzgerald | Li Watsek41% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | Buy Now | 363.65% | JMP Securities | Reni Benjamin46% | → $44 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/12/2023 | Buy Now | 384.72% | Needham | Ami Fadia62% | → $46 | Reiterates | Buy → Buy | Get Alert |
| 09/11/2023 | Buy Now | 247.73% | B. Riley Securities | Kalpit Patel40% | $33 → $33 | Upgrade | Neutral → Buy | Get Alert |
| 09/07/2023 | Buy Now | 584.93% | Cantor Fitzgerald | Li Watsek41% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | 342.57% | Morgan Stanley | Jeffrey Hung56% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/04/2023 | Buy Now | 363.65% | JMP Securities | Reni Benjamin46% | $46 → $44 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | 500.63% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $57 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | 384.72% | Needham | Ami Fadia62% | $48 → $46 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 426.87% | EF Hutton | Tony Butler43% | → $50 | Reiterates | → Buy | Get Alert |
| 05/11/2023 | Buy Now | 384.72% | JMP Securities | Reni Benjamin46% | $46 → $46 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/08/2023 | Buy Now | 479.56% | Oppenheimer | Jay Olson62% | → $55 | Reiterates | → Outperform | Get Alert |
| 05/05/2023 | Buy Now | 384.72% | JMP Securities | Reni Benjamin46% | → $46 | Reiterates | → Market Outperform | Get Alert |
| 05/05/2023 | Buy Now | 500.63% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $57 | Reiterates | → Buy | Get Alert |
| 05/05/2023 | Buy Now | 574.39% | Needham | Ami Fadia62% | $67 → $64 | Maintains | Buy | Get Alert |
| 04/19/2023 | Buy Now | 479.56% | EF Hutton | Tony Butler43% | → $55 | Reiterates | → Buy | Get Alert |
| 04/18/2023 | Buy Now | 384.72% | JMP Securities | Reni Benjamin46% | → $46 | Reiterates | → Market Outperform | Get Alert |
| 03/01/2023 | Buy Now | 500.63% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $57 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | Buy Now | 606.01% | Needham | Ami Fadia62% | $72 → $67 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 479.56% | EF Hutton | Tony Butler43% | → $55 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | Buy Now | 679.77% | Cantor Fitzgerald | Li Watsek41% | → $74 | Reiterates | → Overweight | Get Alert |
| 02/15/2023 | Buy Now | 479.56% | EF Hutton | Tony Butler43% | → $55 | Reiterates | → Buy | Get Alert |
| 02/15/2023 | Buy Now | 500.63% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $57 | Reiterates | → Buy | Get Alert |
| 02/15/2023 | Buy Now | 658.69% | Needham | Ami Fadia62% | → $72 | Reiterates | → Buy | Get Alert |
| 01/05/2023 | Buy Now | 479.56% | EF Hutton | Tony Butler43% | → $55 | Initiates | → Buy | Get Alert |
| 11/09/2022 | Buy Now | 384.72% | JMP Securities | Reni Benjamin46% | $70 → $46 | Maintains | Market Outperform | Get Alert |
| 09/12/2022 | Buy Now | 374.18% | Morgan Stanley | Jeffrey Hung56% | $60 → $45 | Maintains | Equal-Weight | Get Alert |
| 08/31/2022 | Buy Now | — | Cowen & Co. | Tara Bancroft66% | — | Initiates | → Outperform | Get Alert |
| 08/22/2022 | Buy Now | 426.87% | SVB Leerink | Jonathan Chang38% | $48 → $50 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 405.8% | SVB Leerink | Jonathan Chang38% | $69 → $48 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 500.63% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $65 → $57 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 216.12% | Barclays | Peter Lawson42% | → $30 | Initiates | → Overweight | Get Alert |
| 07/06/2022 | Buy Now | 532.24% | Canaccord Genuity | William Maughan71% | → $60 | Assumes | → Buy | Get Alert |
| 05/23/2022 | Buy Now | 289.88% | Piper Sandler | Edward Tenthoff52% | $76 → $37 | Maintains | Overweight | Get Alert |
| 05/06/2022 | Buy Now | 627.08% | SVB Leerink | Jonathan Chang38% | $70 → $69 | Maintains | Outperform | Get Alert |
| 04/13/2022 | Buy Now | 247.73% | B. Riley Securities | Kalpit Patel40% | $62 → $33 | Downgrade | Buy → Neutral | Get Alert |
| 04/12/2022 | Buy Now | 690.31% | Needham | Ami Fadia62% | $85 → $75 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ:BCYC) was reported by Needham on March 11, 2025. The analyst firm set a price target for $30.00 expecting BCYC to rise to within 12 months (a possible 216.12% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bicycle Therapeutics (BCYC)?
The latest analyst rating for Bicycle Therapeutics (NASDAQ:BCYC) was provided by Needham, and Bicycle Therapeutics reiterated their buy rating.
When was the last upgrade for Bicycle Therapeutics (BCYC)?
The last upgrade for Bicycle Therapeutics PLC happened on September 12, 2023 when B. Riley Securities raised their price target to $33. B. Riley Securities previously had a neutral for Bicycle Therapeutics PLC.
When was the last downgrade for Bicycle Therapeutics (BCYC)?
The last downgrade for Bicycle Therapeutics PLC happened on August 7, 2024 when B. Riley Securities changed their price target from $33 to $28 for Bicycle Therapeutics PLC.
When is the next analyst rating going to be posted or updated for Bicycle Therapeutics (BCYC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bicycle Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bicycle Therapeutics was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
Is the Analyst Rating Bicycle Therapeutics (BCYC) correct?
While ratings are subjective and will change, the latest Bicycle Therapeutics (BCYC) rating was a reiterated with a price target of $30.00 to $30.00. The current price Bicycle Therapeutics (BCYC) is trading at is $9.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.